Probiotics are lactic acid bacteria which are used extensively in therapeutic preparations
and added to foods. There are many studies which have demonstrated the effects of …

Previous studies have reported that probiotics may improve clinical and inflammatory
parameters in patients with obesity and metabolic syndrome (MetS). Lactobacillus (L.) …

Background. Considering the observed role of probiotics in modulating gut microbiome,
probiotics are discussed to be one potential complementary therapy for obesity …

The microbiota inhabiting the human gastro-intestinal tract is reported to have a significant
impact on the health of an individual. Recent findings suggest that the microbial imbalance …

Obesity and insulin resistance are the major predisposing factors to comorbidities, such as
Type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular and neurodegenerative …

Obesity and its comorbidities are humans' most prevalent cardio-metabolic diseases
worldwide. Recent evidence has shown that chronic low-grade inflammation is a common …

Lactobacilli are reported to reduce weight gain, the mechanism has not been well
elucidated. In this study mice received either normal-chow-diet or high–fat-diet (HFD), and …

Imbalances in the gut microbiota, the bacteria that inhabit the intestines, are central to the
pathogenesis of obesity. This systematic review assesses the association between the gut …

The World Health Organization (WHO) reports that 400 million people are obese, and over
1.6 billion adults are overweight worldwide. Annually, over 2.8 million people die from …

Background and aims Obese children are more prone to becoming obese adults, and
excess adiposity consequently increases the risk of many complications, such as metabolic …